IndIcatIon: SIMBADOL is indicated for the control of postoperative pain associated with surgical procedures in cats.
IMPoRtant SaFEtY InFoRMatIon
Wa R nInGS, PREcaU t IonS and contRaIndIcatI on S: due to serious human safety and abuse concerns,
including physical or psychological dependence, life-threatening respiratory depression and additive
cn S depressant effects, read the full prescribing information before using this drug, including the
complete Boxed Warning. not for use in humans. Hospital staff should be trained in the handling of
potent opioids and should avoid accidental exposure. For subcutaneous (SQ) injectable use in cats. Opioid
excitation has been observed up to 8 hours after anesthetic recovery. Use with caution in cats with impaired hepatic
function. SIMBADOL has not been evaluated in breeding, pregnant, or lactating cats, in cats younger than 4 months
of age or moribund cats. Do not use in cats with known hypersensitivity to buprenorphine hydrochloride or any of the
components of SIMBADOL, or known intolerance to opioids.
See attached full Prescribing Information, including the complete Boxed Warning for human safety
and adverse reactions.
24-hour
*Administered subcutaneously for up to 3 days.
Fda
aPPRovEd
OnLy BUprenOrphIne
FoR catS
The frstandonlybuprenorphineFda approved for cats
Demonstrated safety andeffcacyinmore than 200 cats treated with SIMBADOL
Up to 3 once-daily subcutaneous doses for a total of 72 hours of pain control
AlltrademarksarethepropertyofZoetisInc.,itsaffliatesand/oritslicensors.
©2015 Zoetis Inc. All rights reserved. April 2015. SIM-00014
once-daily* surgical pain control
Learn more at
www.ZoetisUS.com/Simbadol